2nd International Conference on Non-invasive Cardiac Imaging, Nuclear Cardiology & Echocardiography
Amsterdam, Netherlands
Peter J Blankestijn
University Medical Center Utrecht, The Netherlands
Title: Renal denervation: present situation and perspectives for the future
Biography
Biography: Peter J Blankestijn
Abstract
Renal denervation has been introduced for the treatment of resistance hypertension. There is considerable theoretical and experimental evidence that renal denervation may be an effective antihypertensive treatment. Presently available clinical evidence in conflicting, but large randomized controlled trials are underway and first results will be presented later in 2017.
In this presentation the present status on safety and efficacy and considerations for the future of renal denervation in hypertensive patients will be discussed. It is now clear that poor medication adherence is a common finding is resistant hypertension patients. How this interacts with renal denervation will be addressed. Finally, possible other patient groups that may benefit of renal denervation are mentioned as well.